目的:探讨595 nm脉冲染料激光与重组人表皮生长因子(rhEGF)治疗面部瘢痕的疗效。方法:随机选取80例面部瘢痕患者。分为对照组(n = 40,595 nm激光治疗)与研究组(n = 40,595 nm激光治疗联合rhEGF),对比两组瘢痕面积、瘢痕愈合情况及评分、满意度。结果:研究组在瘢痕面积、结痂与痂皮脱落时间、创面愈合时间、瘢痕上的评分均显著低于对照组(P Objective: To investigate the efficacy of 595 nm pulsed dye laser combined with recombinant human epidermal growth factor (rhEGF) in the treatment of facial scars. Methods: A total of 80 patients with facial scars were randomly selected and divided into a control group (n = 40, treated with 595 nm laser alone) and a study group (n = 40, treated with 595 nm laser combined with rhEGF). The scar area, scar healing status, scar score, and patient satisfaction were compared between the two groups. Results: The study group showed significantly lower scar area, shorter scab and eschar shedding time, faster wound healing time, and lower scar scores compared to the control group (P < 0.05). Additionally, patient satisfaction was significantly higher in the study group than in the control group (P < 0.05). Conclusion: The combination of 595 nm pulsed dye laser and rhEGF exhibits remarkable efficacy in the treatment of facial scars, promoting wound healing, reducing scar area, and improving facial scar conditions.
目的比较混频超声波导入与封包复方利多卡因乳膏的镇痛效果。方法选择2021年9月至2022年4月在广西医科大学第一附属医院就诊的50例面部瘢痕为研究对象。将患者面部两侧随机分为观察组和对照组,分别行混频超声波导入或封包,对比疼痛评分、不良反应、术中伴随症状、满意度。结果观察组术中VAS、术后5 min VAS、术中NRS、术中FPS-R的疼痛评分低于对照组,差异有统计学意义(P<0.05)。观察组不良反应率、术中伴随症状发生率低于对照组,差异无统计学意义(P>0.05);观察组满意度高于对照组,差异有统计学意义(P<0.05)。结论混频超声波导入复方利多卡因乳膏较局部封包在微等离子束治疗面部瘢痕中提高镇痛效果,未增加不良反应,提高患者满意度。
